Adalberto Brach del Prever

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

Stefano Ferrari, Sigbjørn Smeland, Mario Mercuri et al. · Journal of Clinical Oncology · 2005 · 432 citations

Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

Stefano Ferrari, A Briccoli, Mario Mercuri et al. · Journal of Clinical Oncology · 2003 · 312 citations · Full text

Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin

G. Bacci, Piero Picci, Pietro Ruggieri et al. · Cancer · 1990 · 235 citations · Full text

Surgical Oncology, Medicine, Cancer Management +14

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

Stefano Ferrari, Kirsten Sundby Hall, Roberto Luksch et al. · Annals of Oncology · 2010 · 125 citations · Full text

Surgical Oncology, Malignant Disease, Medicine +6

Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed

Stefano Ferrari, Francesca Perut, Franca Fagioli et al. · Journal of Translational Medicine · 2013 · 125 citations · Full text